Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Ehrhardt

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
The Journal of General Virology|November 19, 2010
Transcriptional activity of inverted terminal repeats of various human adenovirus serotypesChristina Rauschhuber, Armin Wolf, Anja Ehrhardt
Journal of Virology|June 14, 2003
Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivoAnja Ehrhardt, Hui Xu, Mark A Kay
Pharmazie in Unserer Zeit|June 24, 2011
[Lifelong healing via gene transfer - reality or utopia? Stable versus transient gene transfer]Hans-Joachim Lipps, Wolfgang Hammerschmidt, Anja Ehrhardt
Human Gene Therapy|April 27, 2010
Critical amino acid residues within the φC31 integrase DNA-binding domain affect recombination activities in mammalian cellsRaphael Liesner, Wenli Zhang, Nadja Noske, et al.
Nature Reviews. Genetics|May 3, 2003
Progress and problems with the use of viral vectors for gene therapyClare E Thomas, Anja Ehrhardt, Mark A Kay
FEBS Letters|November 24, 2019
State-of-the-art human adenovirus vectorology for therapeutic approachesJian Gao, Kemal Mese, Oskar Bunz, et al.
The Journal of General Virology|November 1, 2015
Adenovirus hexon modifications influence in vitro properties of pseudotyped human adenovirus type 5 vectorsManish Solanki, Wenli Zhang, Liu Jing, et al.
World Journal of Hepatology|March 3, 2015
Gene therapeutic approaches to inhibit hepatitis B virus replicationMaren Gebbing, Thorsten Bergmann, Eric Schulz, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 8, 2017
Establishment of the CRISPR/Cas9 System for Targeted Gene Disruption and Gene TaggingEric Ehrke-Schulz, Maren Schiwon, Claudia Hagedorn, et al.
Human Gene Therapy|September 1, 2017
Recent Advances in Preclinical Developments Using Adenovirus Hybrid VectorsEric Ehrke-Schulz, Wenli Zhang, Jian Gao, et al.
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
The Journal of General Virology|November 19, 2010
Transcriptional activity of inverted terminal repeats of various human adenovirus serotypesChristina Rauschhuber, Armin Wolf, Anja Ehrhardt
Journal of Virology|June 14, 2003
Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivoAnja Ehrhardt, Hui Xu, Mark A Kay
Pharmazie in Unserer Zeit|June 24, 2011
[Lifelong healing via gene transfer - reality or utopia? Stable versus transient gene transfer]Hans-Joachim Lipps, Wolfgang Hammerschmidt, Anja Ehrhardt
Human Gene Therapy|April 27, 2010
Critical amino acid residues within the φC31 integrase DNA-binding domain affect recombination activities in mammalian cellsRaphael Liesner, Wenli Zhang, Nadja Noske, et al.
Nature Reviews. Genetics|May 3, 2003
Progress and problems with the use of viral vectors for gene therapyClare E Thomas, Anja Ehrhardt, Mark A Kay
FEBS Letters|November 24, 2019
State-of-the-art human adenovirus vectorology for therapeutic approachesJian Gao, Kemal Mese, Oskar Bunz, et al.
The Journal of General Virology|November 1, 2015
Adenovirus hexon modifications influence in vitro properties of pseudotyped human adenovirus type 5 vectorsManish Solanki, Wenli Zhang, Liu Jing, et al.
World Journal of Hepatology|March 3, 2015
Gene therapeutic approaches to inhibit hepatitis B virus replicationMaren Gebbing, Thorsten Bergmann, Eric Schulz, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 8, 2017
Establishment of the CRISPR/Cas9 System for Targeted Gene Disruption and Gene TaggingEric Ehrke-Schulz, Maren Schiwon, Claudia Hagedorn, et al.
Human Gene Therapy|September 1, 2017
Recent Advances in Preclinical Developments Using Adenovirus Hybrid VectorsEric Ehrke-Schulz, Wenli Zhang, Jian Gao, et al.
Pageof 13